Nootropics

Ginkgo Biloba

Evidence: strong_human

Mechanism of Action

Standardized extract (EGb 761) contains flavonoid glycosides (24%) and terpene lactones (6% — ginkgolides A/B/C and bilobalide) that act through multiple pathways: potent free radical scavenging and inhibition of membrane lipid peroxidation; antagonism of platelet-activating factor (PAF) via ginkgolides; enhancement of cerebral blood flow through nitric oxide-mediated vasodilation and reduced blood viscosity; and increased prefrontal dopamine and acetylcholine release via acylated flavonol glycosides. Bilobalide provides direct neuroprotection against excitotoxicity and mitochondrial dysfunction.

Dosing Protocol

Standard: 120-240 mg/day of standardized extract (24% flavone glycosides, 6% terpene lactones) divided into 2-3 doses

Maintenance: 120-240 mg/day; 240 mg/day for cognitive impairment

Administration: oral

Timing: With or without food. Split into 2-3 doses throughout the day. Effects may take 4-6 weeks to manifest.

Duration: Ongoing; no cycling required. Clinical trials typically run 22-26 weeks.

Notes

The most extensively studied herbal nootropic with over 400 clinical trials. Meta-analyses confirm efficacy for dementia (240 mg/day EGb 761) but evidence for cognitive enhancement in healthy young adults is weaker. The bleeding risk is the most clinically significant concern — must be discontinued before surgery and never combined with anticoagulants. The GEM trial (2008, n=3069) found no benefit for dementia prevention in healthy elderly, but this was for prevention rather than treatment. Best suited for older adults with mild cognitive impairment or cerebrovascular insufficiency rather than healthy young people seeking enhancement.

Stacking

  • Vinpocetine
  • Phosphatidylserine
  • Bacopa Monnieri
  • Panax Ginseng

Interactions

  • Anticoagulants (Warfarin, Heparin) [HIGH] — Ginkgolides are PAF antagonists — significantly increased bleeding risk; avoid combination
  • Antiplatelet agents (Aspirin, Clopidogrel) [HIGH] — Additive antiplatelet effects; spontaneous bleeding including intracranial hemorrhage reported
  • SSRIs/SNRIs [MEDIUM] — Case reports of serotonin syndrome; additive serotonergic effects possible
  • NSAIDs (Ibuprofen) [MEDIUM] — Increased bleeding risk via combined antiplatelet mechanisms
  • CYP3A4/CYP2C9 substrates [LOW] — Ginkgo may induce these enzymes, potentially reducing efficacy of certain drugs

Contraindications

  • Bleeding disorders
  • Upcoming surgery (discontinue 2 weeks prior)
  • Seizure disorders (ginkgotoxin in poorly standardized extracts may lower seizure threshold)
  • Pregnancy (may increase bleeding risk)

Side Effects

  • Headache
  • GI distress
  • Dizziness
  • Allergic skin reactions
  • Increased bleeding risk

Key Papers

  • 10.2147/CIA.S72728
  • 10.3233/JAD-140837
  • 10.1007/s10072-003-0134-y

Source Quality

EGb 761 (Schwabe Pharmaceuticals) is the gold-standard extract with the vast majority of clinical evidence. Must be standardized to 24% flavone glycosides and 6% terpene lactones with <5 ppm ginkgolic acids (toxic). Avoid raw leaf preparations which contain variable ginkgolic acid levels. Generic standardized extracts exist but clinical equivalence to EGb 761 is not guaranteed.

Disclaimer: This information is for educational purposes only and is not medical advice. BioAccelera Labs does not diagnose, treat, or prescribe. Consult a licensed healthcare provider before using any compound.

Should Ginkgo Biloba Be in Your Stack?

Take the free assessment and get personalized recommendations based on your biology and goals.

Get Your Free Protocolor take the assessment →
← Browse All 231 Compounds